✦ LIBER ✦

Renal insufficiency and its relation to ischemic and bleeding outcomes with tirofiban versus abciximab in the TARGET trial

✍ Scribed by Peter B. Berger; David J. Moliterno; Jennifer White; Patricia J. Best; Albert W. Chan; Steen D. Kristensen; David R. Holmes Jr.; Peter M. DiBattiste; Howard C. Herrmann; Eric J. Topol

Book ID: 119543670
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 122 KB
Volume: 39
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(02)80114-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of abciximab versus tirofiban on

Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes—observations from the TARGET trial

✍ Ivan P Casserly; Eric J Topol; Gang Jia; Richard A Lange; Christian Hamm; Bernha 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 186 KB

The relation of renal function to ischem

The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: The Do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial

✍ Peter B. Berger; Patricia J.M. Best; Eric J. Topol; Jennifer White; Peter M. DiB 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Prolongation of activated clotting time

Prolongation of activated clotting time (ACT) with tirofiban versus abciximab and its association to outcome: results from TARGET

✍ David J. Moliterno; Richard A. Lange; Christian Hamm; Bernhard Meier; Peter M. D 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Predictive factors for ischemic target v

Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial

✍ Mandeep Singh; Bernard J. Gersh; Robyn L. McClelland; Kalon K.L. Ho; James T. Wi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Gender Differences in Outcomes After Pri

Gender Differences in Outcomes After Primary Angioplasty Versus Primary Stenting With and Without Abciximab for Acute Myocardial Infarction: Results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial

✍ A.J. Lansky; C. Piedras; R.A. Costa 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Gender Differences in Outcomes After Pri

✍ Lansky, A. J. 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 438 KB